نتایج جستجو برای: cefepime

تعداد نتایج: 1628  

Journal: :The Journal of antimicrobial chemotherapy 2002
Vincent H Tam Peggy S McKinnon Ronda L Akins Michael J Rybak George L Drusano

We conducted a prospective, open-label study to delineate a relationship between exposure and outcomes in 36 patients treated with cefepime. Twenty patients had documented Gram-negative infections. Timed blood and urine samples were obtained at steady state to determine pharmacokinetic and pharmacodynamic parameters. Microbiological success was significantly correlated with the proportion of th...

Journal: :Antimicrobial agents and chemotherapy 2003
Véronique Dubois Corinne Arpin Claudine Quentin Jeannette Texier-Maugein Laurent Poirel Patrice Nordmann

The most frequent extended-spectrum -lactamases (ESBLs) in members of the family Enterobacteriaceae are derived from the clavulanic acid-inhibited Ambler class A enzymes TEM-1/ TEM-2 and SHV-1, which may hydrolyze ceftazidime and cefepime (4, 5). The Ambler class B enzymes have the broadest hydrolysis profiles, including cefepime and ceftazidime (8), whereas several OXA-derived ESBLs (Ambler cl...

Journal: :Clinical Infectious Diseases 2009

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013
Jerry Altshuler Samuel L Aitken David Guervil Diana Esaian John Papadopoulos Cesar A Arias

TO THE EDITOR—We read Lee et al's article in the 15 February 2013 issue of Clinical Infectious Diseases with great interest [1]. In this retrospective cohort, Lee et al showed that 17 propensity-score-matched patients had increased mortality when treated with cefepime, as compared to carbapenems, as definitive therapy for extended-spectrum β-lacta-mase (ESBL)–producing Enterobacteria-ceae. This...

Journal: : 2023

Researchers need to identify the nephrotoxic properties of medicinal products both during preclinical development and when exploring options optimise pharmacotherapy. The main challenge is find an experimental model for assessing drug-induced nephrotoxicity that reflects in vivo conditions as closely possible. aim study was compare susceptibility HEK293 RPTEC cell lines used models cefuroxime c...

Journal: :International journal of antimicrobial agents 2010
Mickaël Riou Sylviane Carbonnelle Laëtitia Avrain Narcisa Mesaros Jean-Paul Pirnay Florence Bilocq Daniel De Vos Anne Simon Denis Piérard Frédérique Jacobs Anne Dediste Paul M Tulkens Françoise Van Bambeke Youri Glupczynski

Pseudomonas aeruginosa causes severe nosocomial pneumonia in Intensive Care Unit (ICU) patients, with an increased prevalence of multiresistant strains. We examined the impact of the use of antipseudomonal antibiotic(s) on the susceptibility of P. aeruginosa isolated from ICU patients with clinically suspected hospital-acquired pneumonia collected in five teaching hospitals (110 non-duplicate i...

Journal: :The Journal of antimicrobial chemotherapy 2011
Nathalie Vernaz Benedikt Huttner Daniel Muscionico Jean-Luc Salomon Pascal Bonnabry José Maria López-Lozano Arielle Beyaert Jacques Schrenzel Stephan Harbarth

OBJECTIVES To determine the temporal relationship between antibiotic use and incidence of antibiotic-resistant Escherichia coli in both the inpatient and outpatient setting of a large urban area. METHODS A retrospective observational time-series analysis was performed to evaluate the incidence of non-duplicate clinical isolates of E. coli resistant to ciprofloxacin, trimethoprim/sulfamethoxaz...

Journal: :Antimicrobial agents and chemotherapy 2008
David L Paterson Carlene A Muto Magdaline Ndirangu Peter K Linden Brian A Potoski Blair Capitano Robert A Bonomo David C Aron Curtis J Donskey

In contrast to expanded-spectrum cephalosporins, beta-lactam-beta-lactamase inhibitor combinations such as piperacillin-tazobactam have rarely been associated with vancomycin-resistant Enterococcus (VRE) colonization and infection. In mice, piperacillin-tazobactam has sufficient antienterococcal activity to inhibit the establishment of colonization during treatment, but this effect has not been...

Journal: :American journal of kidney diseases : the official journal of the National Kidney Foundation 2001
K M Wong Y H Chan C Y Cheung W L Chak K S Choi S H Leung J Leung K F Chau D N Tsang C S Li

Cefepime is a cephalosporin with a broad spectrum of activity against most gram-positive and gram-negative pathogens. In this study, we attempted to compare the safety and efficacy of cefepime monotherapy against the potentially more toxic combination of vancomycin and netilmicin in the treatment of continuous ambulatory peritoneal dialysis (CAPD)-associated bacterial peritonitis. Eighty-one co...

2015
Agnieszka E. Laudy Paula Osińska Alicja Namysłowska Olga Zając Stefan Tyski

The production of β-lactamases is the most important mechanism of Gram-negative rod resistance to β-lactams. Resistance to ceftazidime and cefepime in clinical isolates of Enterobacteriaceae (especially ESβL-positive E. coli and K. pneumoniae) and P. aeruginosa is life-threatening. However, all strains of the above mentioned species possess chromosomally encoded RND efflux pump systems in addit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید